NPI: 1578525614 · LANCASTER, SC 29720 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,040 | $148K |
| 2019 | 8,671 | $64K |
| 2020 | 13,136 | $46K |
| 2021 | 11,014 | $44K |
| 2022 | 10,733 | $27K |
| 2023 | 4,695 | $5K |
| 2024 | 1,988 | $5K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 3,292 | 1,664 | $169K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 24,015 | 2,196 | $116K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,064 | 1,364 | $47K |
| J1756 | Injection, iron sucrose, 1 mg | 2,809 | 870 | $3K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 100 | 86 | $1K |
| 83970 | 1,165 | 1,026 | $1K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,843 | 884 | $451.29 |
| 82108 | 497 | 434 | $384.06 | |
| 82728 | 681 | 592 | $348.09 | |
| 83550 | 675 | 596 | $246.22 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 46 | 24 | $244.50 |
| 83540 | 693 | 608 | $186.85 | |
| 85045 | 1,331 | 1,150 | $132.85 | |
| 0001A | 13 | 12 | $130.22 | |
| 85041 | 1,361 | 1,179 | $103.66 | |
| 85048 | 1,328 | 1,149 | $83.40 | |
| 0124A | 16 | 14 | $79.48 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 275 | 143 | $78.07 |
| 90674 | 42 | 42 | $53.48 | |
| G0008 | Administration of influenza virus vaccine | 31 | 31 | $0.00 |